Comment on "Safety of Physostigmine for Pediatric Antimuscarinic Poisoning".

Pires, Kyle D; Goldfrank, Lewis R

Pires, Kyle D; Goldfrank, Lewis R.

Affiliation

Pires KD; Division of Medical Toxicology, Ronald O. Perelman Department of Emergency Medicine, NYU Grossman School of Medicine, New York, USA. kylepires@gmail.com.
Goldfrank LR; Department of Health and Mental Hygiene, New York City Poison Control Center, New York, USA. kylepires@gmail.com.

J Med Toxicol ; 20(4): 438-439, 2024 Oct.

Article in En | MEDLINE | ID: mdl-39080203

Subject(s)

Muscarinic Antagonists; Physostigmine; Humans; Physostigmine/therapeutic use; Muscarinic Antagonists/therapeutic use; Child; Cholinesterase Inhibitors/poisoning; Cholinesterase Reactivators/therapeutic use; Poisoning/therapy; Poisoning/diagnosis; Poisoning/drug therapy

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Physostigmine / Muscarinic Antagonists Limits: Child / Humans Language: En Journal: J Med Toxicol Journal subject: TOXICOLOGIA Year: 2024 Document type: Article Affiliation country: United States Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google